company background image
KMDA

Kamada TASE:KMDA Stock Report

Last Price

₪21.05

Market Cap

₪1.2b

7D

22.9%

1Y

33.2%

Updated

07 Dec, 2023

Data

Company Financials +

KMDA Stock Overview

Kamada Ltd., together with its subsidiaries, provides plasma-derived protein therapeutics.

KMDA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Kamada Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kamada
Historical stock prices
Current Share Price₪21.05
52 Week High₪23.23
52 Week Low₪13.09
Beta0.16
1 Month Change14.46%
3 Month Change2.18%
1 Year Change33.23%
3 Year Change0.72%
5 Year Change16.62%
Change since IPO60.08%

Recent News & Updates

Recent updates

Is Kamada (TLV:KMDA) Using Too Much Debt?

Jan 26
Is Kamada (TLV:KMDA) Using Too Much Debt?

We Discuss Why Kamada Ltd.'s (TLV:KMDA) CEO Compensation May Be Closely Reviewed

Dec 16
We Discuss Why Kamada Ltd.'s (TLV:KMDA) CEO Compensation May Be Closely Reviewed

Investors Who Bought Kamada (TLV:KMDA) Shares Five Years Ago Are Now Up 38%

Mar 01
Investors Who Bought Kamada (TLV:KMDA) Shares Five Years Ago Are Now Up 38%

Is Kamada Ltd. (TLV:KMDA) Popular Amongst Insiders?

Feb 08
Is Kamada Ltd. (TLV:KMDA) Popular Amongst Insiders?

Is Weakness In Kamada Ltd. (TLV:KMDA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 21
Is Weakness In Kamada Ltd. (TLV:KMDA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Kamada Ltd. (TLV:KMDA) Shares Could Be 42% Below Their Intrinsic Value Estimate

Jan 03
Kamada Ltd. (TLV:KMDA) Shares Could Be 42% Below Their Intrinsic Value Estimate

How Many Kamada Ltd. (TLV:KMDA) Shares Have Insiders Sold, In The Last Year?

Dec 15
How Many Kamada Ltd. (TLV:KMDA) Shares Have Insiders Sold, In The Last Year?

Are Kamada's (TLV:KMDA) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 29
Are Kamada's (TLV:KMDA) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Shareholder Returns

KMDAIL BiotechsIL Market
7D22.9%12.9%0.4%
1Y33.2%15.9%-6.7%

Return vs Industry: KMDA exceeded the IL Biotechs industry which returned 15.9% over the past year.

Return vs Market: KMDA exceeded the IL Market which returned -6.7% over the past year.

Price Volatility

Is KMDA's price volatile compared to industry and market?
KMDA volatility
KMDA Average Weekly Movement6.5%
Biotechs Industry Average Movement6.8%
Market Average Movement5.8%
10% most volatile stocks in IL Market9.5%
10% least volatile stocks in IL Market4.0%

Stable Share Price: KMDA is not significantly more volatile than the rest of IL stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: KMDA's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990380Amir Londonhttps://www.kamada.com

Kamada Ltd., together with its subsidiaries, provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD.

Kamada Ltd. Fundamentals Summary

How do Kamada's earnings and revenue compare to its market cap?
KMDA fundamental statistics
Market Cap₪1.21b
Earnings (TTM)₪22.84m
Revenue (TTM)₪560.86m

53.0x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
KMDA income statement (TTM)
RevenueUS$151.53m
Cost of RevenueUS$95.16m
Gross ProfitUS$56.37m
Other ExpensesUS$50.20m
EarningsUS$6.17m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.11
Gross Margin37.20%
Net Profit Margin4.07%
Debt/Equity Ratio0%

How did KMDA perform over the long term?

See historical performance and comparison